Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects
Status:
Completed
Trial end date:
2020-12-12
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, two-period, crossover Phase 1 to assess the impact of
CIN-107 on the pharmacokinetics (PK) of metformin and the safety and tolerability of
coadministration of CIN-107 and metformin as compared to metformin alone.